Pretreatment with low-dose β-adrenergic antagonist therapy does not affect severity of takotsubo cardiomyopathy

Clinical Cardiology

Volumn 35, Issue 8, 2012, Pages 478-481

  Palla, Amruth R ^a   Dande, Amit S ^a   Petrini, Joann ^a   Wasserman, Hal S ^a   Warshofsky, Mark K ^a  

^a DANBURY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEART ENZYME; METOPROLOL SUCCINATE; METOPROLOL TARTRATE;

AGED; ANGIOGRAPHY; DATA BASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; OUTPATIENT; REVIEW; TAKOTSUBO CARDIOMYOPATHY;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TAKOTSUBO CARDIOMYOPATHY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864713601     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21983     Document Type: Review

References (17)

1. Tsai TT, Nallamothu BK, Prasad A, et al. Clinical problem-solving: a change of heart. N Engl J Med. 2009; 361: 1010-1016.
2. Akashi YJ, Goldstein DS, Barbaro G, et al. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008; 118: 2754-2762.
3. Angelini P., Takotsubo cardiomyopathy: what is behind the octopus trap? Tex Heart Inst J. 2010; 37: 85-87.
4. Cho DK, Kim JH, Chung N., Cardiovascular flashlight: transient mid-ventricular ballooning cardiomyopathy associated with bladder pheochromocytoma. Eur Heart J. 2009; 30: 1202.
5. Chattopadhyay S, John J., Tako-tsubo and reverse tako-tsubo cardiomyopathy: temporal evolution of the same disease? Eur Heart J. 2009; 30: 2837.
6. Farzaneh-Far R, Farzaneh-Far A., Cardiovascular events during world cup soccer. N Engl J Med. 2008; 358: 2408-2409. (Pubitemid 351749176)
7. Yoshimura S, Toyoda K, Ohara T, et al. Takotsubo cardiomyopathy in acute ischemic stroke. Ann Neurol. 2008; 64: 547-554.
8. Dewachter P, Mouton-Faivre C., Possible link between apical ballooning syndrome during anaphylaxis and inappropriate administration of epinephrine. Mayo Clin Proc. 2010; 85: 396-398.
9. Yoshioka T, Hashimoto A, Tsuchihashi K, et al. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (tako-tsubo cardiomyopathy). Am Heart J. 2008;155: 526. e1-526. e7.
10. Dünser MW, Hasibeder WR., Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009; 24: 293-316.
11. Wittstein IS, Thiemann DR, Lima JA, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005; 352: 539-548. (Pubitemid 40204667)
12. Akashi YJ, Nakazawa K, Sakakibara M, et al. 123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy. J Nucl Med. 2004; 45: 1121-1127. (Pubitemid 47616042)
13. Ross PJ, Lewis MJ, Henderson AH., Beta-blocker withdrawal syndrome. Lancet. 1979; 1: 875.
14. Migliore F, Bilato C, Isabella G, et al. Haemodynamic effects of acute intravenous metoprolol in apical ballooning syndrome with dynamic left ventricular outflow tract obstruction. Eur J Heart Fail. 2010; 12: 305-308.
15. Good CW, Hubbard CR, Harrison TA, et al. Echocardiographic guidance in treatment of cardiogenic shock complicating transient left ventricular apical ballooning syndrome. JACC Cardiovasc Imaging. 2009; 2: 372-374.
16. White AJ, LaGerche A, Toner GC, et al. Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist. Int J Cardiol. 2009; 131: e92-e94.
17. Fazio G, Pizzuto C, Barbaro G, et al. Chronic pharmacological treatment in takotsubo cardiomyopathy. Int J Cardiol. 2008; 127: 121-123. (Pubitemid 351707512)